Latest Breaking News On - Ashleyl sumrall - Page 1 : vimarsana.com

Women in Oncology honors trailblazing force : Edith P Mitchell, MD, MACP, FCCP, FRCP

Women in Oncology honors trailblazing force : Edith P Mitchell, MD, MACP, FCCP, FRCP
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

University of illinoisUnited statesLynnm schuchterMindy valcarcelEdithp mitchellShikha jainPatriciad wellenbachIshwariam subbiahAlpha kappaElizabeth henry mcdonaldAshleyl sumrallJane cooke wrightJosephg cacchioneKarene knudsenBycassandra jenkinsLevine cancer institute

Novel therapies, technologies give hope for the future to those with brain metastases

Novel therapies, technologies give hope for the future to those with brain metastases
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesCareyk andersDaiichi sankyoMatthias preusserBydrew amorosiAshleyl sumrallManmeets ahluwaliaMindy valcarcelPriscillak brastianosMiami cancer institute baptist health south floridCentral nervous system metastasis center at massMiami cancer instituteDuke university school of medicineUniversity of viennaLevine cancer institute at atrium healthCancer center

8 ASCO studies your colleagues are still talking about

Nearly 7,000 abstracts had been submitted for presentation at this year’s ASCO Annual Meeting.Many have the potential to change practice or improve patient outcomes.

Vorasidenib servierRoys herbstAshleyl sumrallFumiko chinoSamer al hadidiMindy valcarcelAlex herreraHeather wakeleeBristol myers squibbDebu tripathyLegend biotech

Vorasidenib first game changer in 20 years for patients with IDH -mutant grade 2 glioma

CHICAGO — Vorasidenib significantly improved PFS while delaying time to next intervention among certain patients with grade 2 isocitrate dehydrogenase 1- or 2-mutant glioma, according to data presented at ASCO Annual Meeting.The findings, published simultaneously in The New England Journal of Medicine, showed efficacy across all patient subgroups.

United statesDevin mclaughlinBymatthew shinkleDaniel orringerIngok mellinghoffVorasidenib servierAshleyl sumrallDebiopharm groupMemorial sloan kettering cancer centerBlack diamond therapeuticsPuma biotechnologyVoyager therapeuticsGeneral electricThenew england journal